Market Cap | 462.46M | P/E | - | EPS this Y | -13.10% | Ern Qtrly Grth | - |
Income | -14.47M | Forward P/E | -42.81 | EPS next Y | 34.70% | 50D Avg Chg | 3.00% |
Sales | 74.02M | PEG | -0.93 | EPS past 5Y | 15.47% | 200D Avg Chg | 13.00% |
Dividend | N/A | Price/Book | 3.42 | EPS next 5Y | 30.00% | 52W High Chg | -2.00% |
Recommedations | 3.00 | Quick Ratio | 1.87 | Shares Outstanding | 17.43M | 52W Low Chg | 138.00% |
Insider Own | 20.90% | ROA | -2.87% | Shares Float | 11.90M | Beta | 1.35 |
Inst Own | 40.97% | ROE | -10.27% | Shares Shorted/Prior | 160.55K/126.89K | Price | 26.54 |
Gross Margin | 71.11% | Profit Margin | -19.55% | Avg. Volume | 57,138 | Target Price | 28.00 |
Oper. Margin | -12.48% | Earnings Date | Feb 2 | Volume | 157,169 | Change | 0.00% |
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York. As of October 29, 2021, Misonix, Inc. operates as a subsidiary of Bioventus Inc.
BTIG | Neutral | Aug 2, 21 |
Craig-Hallum | Hold | Jul 30, 21 |
Canaccord Genuity | Hold | Jul 30, 21 |
Canaccord Genuity | Buy | May 15, 20 |
BTIG | Buy | Apr 3, 20 |
BTIG Research | Buy | Jun 12, 19 |
Craig-Hallum | Buy | Sep 11, 18 |
Canaccord Genuity | Buy | Aug 24, 18 |
Sidoti & Co. | Buy | Dec 25, 14 |